Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8231465 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 9 Pages |
Abstract
This study suggests that Survivin may be a potentially important prognostic marker and promising therapeutic target in metastatic prostate cancer.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Min M.D., Ph.D., John J. M.D., Yoshiyuki M.D., Ph.D., Michael R. B.S., Andrzej Ph.D., Li-Yan M.D., Alan M.D., Ph.D., Yifen M.D., Anthony L. M.D., William U. M.D., Arnab M.D.,